Massachusetts General Hospital
Charlestown, Massachusetts, United States
Alexandra-Chloé Villani is an Assistant Professor of Medicine at Harvard Medical School and an Associate Member of the Broad Institute. She holds the positions of Principal Investigator at the Massachusetts General Hospital (MGH) Center for Cancer Research and at the MGH Center for Immunology and Inflammatory Diseases, where she is also the Director of the Single Cell Genomics Research Program. As a postdoctoral fellow, she developed new systems immunology and single-cell genomics strategies to define key components regulating human immune response that led to identifying novel human blood immune cell populations. Her laboratpru aims at achieving a higher resolution definition and functional characterization of cell subsets and rules governing human immune response regulation as a foundation for deciphering how immunity is dysregulated in diseases through studying and modeling human immune responses as a function of “healthy” and inflammatory states, disease progression, and response to treatment. The lab is also actively involved in coordinating the Human Immune Cell Atlas Initiative and is working towards developing a comprehensive human immune lexicon that is key to promoting effective bench-to-bedside translation of findings. Dr. Villani is the recipient of several honors, including the MGH Transformative Scholar in Medicine Award, the Damon Runyon-Rachleff Innovation Award, and the NIH Director’s New Innovator Award.
Immune-Related Adverse Events from Checkpoint Inhibitors
Saturday, October 25, 2025
9:30 AM – 10:00 AM Central Time
Disclosure(s): Merck/MSD: Advisor or Review Panel Member (Terminated, March 14, 2025), Consultant (Terminated, March 14, 2025)
